MUC1 and lung cancer: This MUC1/CD3 bispecific antibody was generated via the connection of an anti-CD3 and anti-MUC1 mAb to a PLGA nanoparticle through a chemical reaction, and this BsAb could also elicit anti-tumor activity in lung cancer samples in another study [43].